fluconazole alvogen (fluconazole portfarma) innrennslislyf, lausn 2 mg/ml
alvogen ehf. - fluconazolum inn - innrennslislyf, lausn - 2 mg/ml
xonvea magasýruþolin tafla 10 mg/10 mg
campuspharma ab - pyridoxinum hýdróklóríð; doxylaminii hýdrógen súkkínat - magasýruþolin tafla - 10 mg/10 mg
xtandi
astellas pharma europe b.v. - enzalutamíð - blöðruhálskirtli - innkirtla meðferð - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.
camcevi
accord healthcare s.l.u. - leuprorelin mesilate - blöðruhálskirtli - innkirtla meðferð - camcevi is indicated for the treatment of hormone dependent advanced prostate cancer and for the treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy.
eligard stungulyfsstofn og leysir, lausn 7,5 mg
recordati industria chimica e farmaceutica s.p.a.* - leuprorelinum acetat - stungulyfsstofn og leysir, lausn - 7,5 mg
eligard stungulyfsstofn og leysir, lausn 45 mg
recordati industria chimica e farmaceutica s.p.a.* - leuprorelinum acetat - stungulyfsstofn og leysir, lausn - 45 mg
eligard stungulyfsstofn og leysir, lausn 22,5 mg
recordati industria chimica e farmaceutica s.p.a.* - leuprorelinum acetat - stungulyfsstofn og leysir, lausn - 22,5 mg
buronil filmuhúðuð tafla 25 mg
medilink a/s - melperonum hýdróklóríð - filmuhúðuð tafla - 25 mg
prometazin actavis filmuhúðuð tafla 25 mg
actavis group ptc ehf. - promethazinum hýdróklóríð - filmuhúðuð tafla - 25 mg
targin forðatafla 10 mg /5 mg
mundipharma a/s - oxycodonum hýdróklóríð; naloxonum hýdróklóríð - forðatafla - 10 mg /5 mg